Medical technology major
Boston Scientific Corporation
) was hit by another patent tiff when Germany-based OrbusNeich
Medical Inc. and its subsidiary, OrbusNeich Medical GmbH enforced
the seizure of more than 190 stent systems from the company.
BECTON DICKINSO (BDX): Free Stock Analysis
BOSTON SCIENTIF (BSX): Free Stock Analysis
CONCEPTUS INC (CPTS): Free Stock Analysis
VASCULAR SOLUTN (VASC): Free Stock Analysis
To read this article on Zacks.com click here.
The latest dispute challenging Boston Scientific is associated
with the patent infringement proceedings against the company in
the Dusseldorf Regional Court. According to OrbusNeich, Boston
Scientific violated the preliminary injunction of the Court which
prohibits it from marketing and selling certain line of stents in
The affected stent lines include Small Vessel, Small Workhorse
and Workhorse Stents under the company's PROMUS Element, PROMUS
Element Plus, OMEGA, TAXUS Element, SYNERGY and Promus PREMIER
portfolio. According to the Court's Apr 30, 2013 ruling, the
geometric pattern of these affected stent lines infringe
OrbusNeich's patent EP1341482.
The stent systems were found at the premises of Boston
Scientific's German subsidiary Boston Scientific Medizintechnik
GmbH in Ratingen on May 15. OrbusNeich has filed parallel patent
infringement lawsuits in The Netherlands and Ireland. OrbusNeich
is also seeking more definitive action in the form of a permanent
injunction and damages.
Last week, Boston Scientific received a patent infringement
Vascular Solutions Inc.
), a provider of medical devices for coronary and peripheral
vascular procedures. Vascular Solutions has filed the complaint
in the U.S. District Court for the District of Minnesota.
According to Vascular Solutions, Boston Scientific infringed
three patents owned by it. The complaint alleges, among other
things, that the production and sale of Guidezilla guide
extension catheter by Boston Scientific, which gained the 510(k)
clearance from the U.S. Food and Drug Administration (FDA) in Mar
2013, infringes the patent landscape of Vascular Solutions'
Amid several patent issues, Boston Scientific carries a Zacks
Rank #3 (Hold). Other medical sector stocks that warrant a look
) carrying a Zacks Rank #1 (Strong Buy) and
Becton Dickinson and Company
), carrying a Zacks Rank #2 (Buy).